March 30, 2017 / 8:47 PM / 5 months ago

BRIEF-Dicerna reports Q4 loss per share $0.68

March 30 (Reuters) - Dicerna Pharmaceuticals Inc

* Dicerna reports fourth quarter and full year 2016 financial and operational results

* Dicerna Pharmaceuticals Inc says anticipates that it will have sufficient cash to fund execution of company's current operating plan into 2019

* Qtrly loss per share $0.68 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below